Head and Neck Carcinoma — Trials

Head and Neck Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

2,921 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 1,013
Recruiting: 533
Ph III recruiting: 91
Growth YoY: +21.4%
Industry share: 20%
Top sponsor: Sun Yat-sen University
Termination share: 33.5%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (347)

clinicaltrialsPublishedShowing 351–400 of 1,205 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT07683507	Becotatug Vedotin Plus PD-1 Inhibitor for Head and Neck Squamous Cell Carcinoma	not yet recruiting	Phase 2	60	Feng LiuOTHER	0	Jul 6, 2026	clinicaltrials
NCT03952585	De-intensified Radiation Therapy With Chemotherapy (Cisplatin) or Immunotherapy (Nivolumab) in Treating Patients With Early-Stage, HPV-Positive, Non-Smoking Associated Oropharyngeal Cancer	active not recruiting	Phase 2 / Phase 3	384	National Cancer Institute (NCI)NIH	2	Jul 2, 2026